BRPI0819328A2 - Inibidores de replicação de vírus da imunodeficiência humana - Google Patents

Inibidores de replicação de vírus da imunodeficiência humana

Info

Publication number: BRPI0819328A2
Authority: BR; Brazil
Prior art keywords: immunodeficiency virus; human immunodeficiency; virus replication; replication inhibitors; inhibitors
Prior art date: 2007-11-15

Application number

Other languages

English (en)

Inventor

Rebekah J Carson

Lee Fader

Stephen Kawai

Serge Landry

Youla S Tsantrizos

Christian Brochu

Sebastien Morin

Mathieu Parisien

Bruno Simoneau

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-15

Filing date

2008-11-03

Publication date

2015-05-12

2008-11-03 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2015-05-12 Publication of BRPI0819328A2 publication Critical patent/BRPI0819328A2/pt

2016-02-10 Publication of BRPI0819328A8 publication Critical patent/BRPI0819328A8/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0819328A 2007-11-15 2008-11-03 Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos BRPI0819328A8 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US98834207P	2007-11-15	2007-11-15
PCT/CA2008/001935 WO2009062288A1 (en)	2007-11-15	2008-11-03	Inhibitors of human immunodeficiency virus replication

Publications (2)

Publication Number	Publication Date
BRPI0819328A2 true BRPI0819328A2 (pt)	2015-05-12
BRPI0819328A8 BRPI0819328A8 (pt)	2016-02-10

Family

ID=40638277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0819328A BRPI0819328A8 (pt)	2007-11-15	2008-11-03	Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos

Country Status (18)

Country	Link
US (1)	US7956068B2 (pt)
EP (2)	EP2574610A1 (pt)
JP (1)	JP5269085B2 (pt)
KR (1)	KR20100108337A (pt)
CN (1)	CN102124011A (pt)
AR (1)	AR069334A1 (pt)
AU (1)	AU2008323561B2 (pt)
BR (1)	BRPI0819328A8 (pt)
CA (1)	CA2705312C (pt)
CL (1)	CL2008003405A1 (pt)
ES (1)	ES2402322T3 (pt)
IL (1)	IL205746A0 (pt)
MX (1)	MX2010005292A (pt)
NZ (1)	NZ585297A (pt)
RU (1)	RU2503679C2 (pt)
TW (1)	TW200920363A (pt)
WO (1)	WO2009062288A1 (pt)
ZA (1)	ZA201003305B (pt)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008525422A (ja) *	2004-12-23	2008-07-17	ファイザー・プロダクツ・インク	抗癌剤として有用な複素芳香族誘導体
US8338441B2 (en)	2009-05-15	2012-12-25	Gilead Sciences, Inc.	Inhibitors of human immunodeficiency virus replication
GB0908394D0 (en)	2009-05-15	2009-06-24	Univ Leuven Kath	Novel viral replication inhibitors
GB0913636D0 (en)	2009-08-05	2009-09-16	Univ Leuven Kath	Novel viral replication inhibitors
CN103140474A (zh)	2010-07-02	2013-06-05	吉里德科学公司	治疗aids的萘-2-基乙酸衍生物
EP2588455B1 (en)	2010-07-02	2018-04-04	Gilead Sciences, Inc.	2-quinolinyl-acetic acid derivatives as hiv antiviral compounds
US8633200B2 (en)	2010-09-08	2014-01-21	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
KR20140003438A (ko)	2010-11-15	2014-01-09	카톨리에케 유니버시테이트 루벤	항바이러스성 축합 헤테로사이클릭 화합물
CA2817896A1 (en) *	2010-11-15	2012-05-24	Viiv Healthcare Uk Limited	Inhibitors of hiv replication
JP2014511859A (ja) *	2011-04-04	2014-05-19	ギリアードサイエンシーズ，インコーポレイテッド	Ｈｉｖインテグラーゼ阻害剤の調製のためのプロセス
EP2508511A1 (en)	2011-04-07	2012-10-10	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2511273B8 (en)	2011-04-15	2019-06-26	Hivih	Inhibitors of viral replication, their process of preparation and their therapeutical uses
MX2013012266A (es)	2011-04-21	2013-11-22	Gilead Sciences Inc	Compuestos de benzotiazol y su uso farmaceutico.
JP6055468B2 (ja) *	2011-07-15	2016-12-27	ヴィーブヘルスケアユーケーリミテッド	アザインドール化合物及びｈｉｖを治療するための方法
US8791108B2 (en)	2011-08-18	2014-07-29	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
US9199959B2 (en)	2011-10-25	2015-12-01	Shionogi & Co., Ltd.	HIV replication inhibitor
WO2013073875A1 (ko) *	2011-11-15	2013-05-23	한국화학연구원	신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법
US9376392B2 (en)	2012-01-04	2016-06-28	Gilead Sciences, Inc.	2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
US9284323B2 (en)	2012-01-04	2016-03-15	Gilead Sciences, Inc.	Naphthalene acetic acid derivatives against HIV infection
US8629276B2 (en)	2012-02-15	2014-01-14	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
US9034882B2 (en) *	2012-03-05	2015-05-19	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
US9006235B2 (en)	2012-03-06	2015-04-14	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
ES2571479T3 (es) *	2012-04-20	2016-05-25	Gilead Sciences Inc	Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
ES2647437T3 (es) *	2012-07-12	2017-12-21	Viiv Healthcare Uk Limited	Compuestos y procedimientos para tratar el VIH
US8906929B2 (en)	2012-08-16	2014-12-09	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
EP2716632A1 (en)	2012-10-05	2014-04-09	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2716639A1 (en)	2012-10-05	2014-04-09	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2719685A1 (en)	2012-10-11	2014-04-16	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
TW201441197A (zh)	2013-01-31	2014-11-01	Shionogi & Co	Ｈｉｖ複製抑制劑
JP2016512511A (ja)	2013-03-13	2016-04-28	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	ヒト免疫不全ウイルス複製の阻害剤
JP2016516692A (ja)	2013-03-13	2016-06-09	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	ヒト免疫不全ウイルス複製の阻害剤
US9655889B2 (en)	2013-03-13	2017-05-23	VIIV Healthcare UK (No.5) Limited	Inhibitors of human immunodeficiency virus replication
WO2014159959A1 (en)	2013-03-14	2014-10-02	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
EP2970297A1 (en)	2013-03-14	2016-01-20	Bristol-Myers Squibb Company	Inhibitors of human immunodeficiency virus replication
EA201690089A1 (ru)	2013-06-11	2017-04-28	Латвийский Институт Органического Синтеза	ТИЕНО[2,3-b]ПИРИДИНЫ КАК МОДУЛЯТОРЫ СОСТОЯНИЯ МНОЖЕСТВЕННОЙ ЛЕКАРСТВЕННОЙ УСТОЙЧИВОСТИ
EP2821104A1 (en)	2013-07-05	2015-01-07	Laboratoire Biodim	Inhibitors of viral replication, their process of preparation and their therapeutical uses
EP2821082A1 (en)	2013-07-05	2015-01-07	Laboratoire Biodim	Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
WO2015123230A1 (en)	2014-02-12	2015-08-20	Bristol-Myers Squibb Company	Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication
US9409922B2 (en)	2014-02-18	2016-08-09	Bristol-Myers Squibb Company	Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication
EP3152215A1 (en)	2014-02-18	2017-04-12	ViiV Healthcare UK (No.5) Limited	Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
WO2015126758A1 (en)	2014-02-18	2015-08-27	Bristol-Myers Squibb Company	Imidazopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
ES2687322T3 (es)	2014-02-19	2018-10-24	VIIV Healthcare UK (No.5) Limited	Inhibidores de la replicación del virus de inmunodeficiencia humana
US9273067B2 (en)	2014-02-19	2016-03-01	Bristol-Myers Squibb Company	Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
PT3116880T (pt)	2014-02-20	2018-05-10	Viiv Healthcare Uk No 5 Ltd	Macrociclos de ácido piridin-3-il acético como inibidores da replicação do vírus da imunodeficiência humana
US9193720B2 (en)	2014-02-20	2015-11-24	Bristol-Myers Squibb Company	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
JP6579549B2 (ja)	2014-05-16	2019-09-25	塩野義製薬株式会社	Ｈｉｖ複製阻害作用を有する３環性複素環誘導体
AU2016271762B2 (en)	2015-05-29	2020-01-23	Shionogi & Co., Ltd.	Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity
WO2017006261A1 (en)	2015-07-06	2017-01-12	VIIV Healthcare UK (No.5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
US10221156B2 (en)	2015-07-08	2019-03-05	VIIV Healthcare UK (No.5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
KR20180025914A (ko)	2015-07-09	2018-03-09	비브 헬스케어 유케이 (넘버5) 리미티드	인간 면역결핍 바이러스 복제의 억제제로서의 피리딘-3-일 아세트산 유도체
KR20180025916A (ko)	2015-07-09	2018-03-09	비브 헬스케어 유케이 (넘버5) 리미티드	인간 면역결핍 바이러스 복제의 억제제로서의 피리딘-3-일 아세트산 유도체
KR20180035910A (ko)	2015-08-07	2018-04-06	비브 헬스케어 유케이 (넘버5) 리미티드	인간 면역결핍 바이러스 복제의 억제제로서 피리딘-3-일 아세트산 유도체
BR112018002681A2 (pt)	2015-08-10	2019-04-24	Viiv Healthcare Uk No 5 Ltd	?composto, composição, e, método para tratamento de infecção por hiv?
TWI657086B (zh)	2015-08-11	2019-04-21	英商Viiv醫療保健英國(No.5)有限公司	做為人類免疫缺陷病毒複製抑制劑之５－（ｎ－苯甲基四氫異喹啉－６－基）吡啶－３－基乙酸衍生物
AU2016306088A1 (en)	2015-08-12	2018-03-08	VIIV Healthcare UK (No.5) Limited	5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
EP3334722A1 (en)	2015-08-12	2018-06-20	VIIV Healthcare UK (No.5) Limited	5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3- yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
TW201718537A (zh)	2015-08-12	2017-06-01	Ｖｉｉｖ醫療保健英國（Ｎｏ．５）有限公司	做為人類免疫缺陷病毒複製抑制劑之吡啶－３－基乙酸衍生物
BR112018003181A2 (pt)	2015-08-20	2018-09-25	Viiv Healthcare Uk No 5 Ltd	composto, composição, e, método para tratar infecção por hiv
EP3455217A1 (en)	2016-05-11	2019-03-20	ViiV Healthcare UK (No.5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
JP2019515939A (ja)	2016-05-11	2019-06-13	ヴィーブヘルスケアユーケー（ナンバー５）リミテッド	ヒト免疫不全ウイルス複製の阻害剤としてのピリジン−３−イル酢酸誘導体
US10407410B2 (en)	2016-05-11	2019-09-10	VIIV Healthcare UK (No.5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
EP3497075B1 (de) *	2016-08-12	2020-08-05	Bayer CropScience Aktiengesellschaft	Verfahren zur herstellung von substituierten styrol-derivaten
TW201835068A (zh)	2017-01-03	2018-10-01	英商Viiv醫療保健英國(No.5)有限公司	作為人類免疫缺乏病毒複製之抑制劑之吡啶-3-基乙酸衍生物
US20200016136A1 (en)	2017-01-03	2020-01-16	Viiv Healthcare Uk (No. 5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
WO2019244066A2 (en)	2018-06-19	2019-12-26	VIIV Healthcare UK (No.5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
WO2020003093A1 (en)	2018-06-25	2020-01-02	VIIV Healthcare UK (No.5) Limited	Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
MX2021000293A (es)	2018-07-09	2021-07-15	Boehringer Ingelheim Animal Health Usa Inc	Compuestos heterociclicos antihelminticos.
EP3929185A4 (en) *	2019-02-19	2023-02-15	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	NITROGEN CONDENSED CYCLIC COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
KR20220002890A (ko)	2019-03-19	2022-01-07	뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드	구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
BR112022024156A2 (pt)	2020-05-29	2023-02-14	Boehringer Ingelheim Animal Health Usa Inc	Compostos heterocílicos antelmínticos
WO2023073641A1 (en)	2021-11-01	2023-05-04	Boehringer Ingelheim Vetmedica Gmbh	Anthelmintic pyrrolopyridazine compounds
CN114436879A (zh) *	2022-01-14	2022-05-06	海南三帝制药有限公司	一种盐酸三甲卡因的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8804448D0 (en) *	1988-02-25	1988-03-23	Smithkline Beckman Intercredit	Compounds
WO1993004047A1 (en) *	1991-08-16	1993-03-04	Merck & Co., Inc.	Quinazoline derivatives as inhibitors of hiv reverse transcriptase
WO1996014319A1 (en) *	1994-11-08	1996-05-17	Takeda Chemical Industries, Ltd.	Thienopyridine or thienopyrimidine derivatives and their use
US5620997A (en) *	1995-05-31	1997-04-15	Warner-Lambert Company	Isothiazolones
FR2761687B1 (fr) *	1997-04-08	2000-09-15	Centre Nat Rech Scient	Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
SK6652000A3 (en) *	1997-11-11	2002-05-09	Pfizer Prod Inc	Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
FR2819507B1 (fr) *	2001-01-17	2007-09-28	Inst Rech Developpement Ird	Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus
EP2335700A1 (en) *	2001-07-25	2011-06-22	Boehringer Ingelheim (Canada) Ltd.	Hepatitis C virus polymerase inhibitors with a heterobicylic structure
FR2839646B1 (fr) *	2002-05-17	2008-04-11	Bioalliance Pharma	Utilisation de derives de quinoleine a effet anti-integrase et ses applications
ATE404537T1 (de) *	2002-08-13	2008-08-15	Shionogi & Co	Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
US20060094755A1 (en) *	2004-10-28	2006-05-04	Bioflexis, Llc	Novel quinoline-based metal chelators as antiviral agents
WO2006103399A1 (en)	2005-03-31	2006-10-05	Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa	Hiv integrase inhibitors
DK3187225T3 (da)	2005-04-28	2022-02-28	Viiv Healthcare Co	Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet
JP5094725B2 (ja)	2005-10-04	2012-12-12	イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ	Ｈｉｖインテグラーゼ阻害剤
TW200800988A (en)	2005-10-27	2008-01-01	Shionogi & Amp Co Ltd	Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
US7939545B2 (en) *	2006-05-16	2011-05-10	Boehringer Ingelheim International Gmbh	Inhibitors of human immunodeficiency virus replication

2008
- 2008-11-03 KR KR1020107013084A patent/KR20100108337A/ko not_active Ceased
- 2008-11-03 BR BRPI0819328A patent/BRPI0819328A8/pt not_active IP Right Cessation
- 2008-11-03 ES ES08850892T patent/ES2402322T3/es active Active
- 2008-11-03 AU AU2008323561A patent/AU2008323561B2/en not_active Ceased
- 2008-11-03 US US12/743,143 patent/US7956068B2/en active Active
- 2008-11-03 NZ NZ585297A patent/NZ585297A/en not_active IP Right Cessation
- 2008-11-03 WO PCT/CA2008/001935 patent/WO2009062288A1/en not_active Ceased
- 2008-11-03 EP EP12199561A patent/EP2574610A1/en not_active Withdrawn
- 2008-11-03 CA CA2705312A patent/CA2705312C/en not_active Expired - Fee Related
- 2008-11-03 JP JP2010533394A patent/JP5269085B2/ja active Active
- 2008-11-03 MX MX2010005292A patent/MX2010005292A/es active IP Right Grant
- 2008-11-03 CN CN2008801247470A patent/CN102124011A/zh active Pending
- 2008-11-03 EP EP08850892A patent/EP2220095B1/en active Active
- 2008-11-03 RU RU2010123989/04A patent/RU2503679C2/ru not_active IP Right Cessation
- 2008-11-14 AR ARP080104989A patent/AR069334A1/es not_active Application Discontinuation
- 2008-11-14 CL CL2008003405A patent/CL2008003405A1/es unknown
- 2008-11-14 TW TW097144270A patent/TW200920363A/zh unknown
2010
- 2010-05-11 ZA ZA2010/03305A patent/ZA201003305B/en unknown
- 2010-05-13 IL IL205746A patent/IL205746A0/en unknown

Also Published As

Publication number	Publication date
RU2503679C2 (ru)	2014-01-10
WO2009062288A1 (en)	2009-05-22
ZA201003305B (en)	2011-03-30
TW200920363A (en)	2009-05-16
MX2010005292A (es)	2010-07-05
JP5269085B2 (ja)	2013-08-21
EP2220095A4 (en)	2011-01-26
EP2220095A1 (en)	2010-08-25
ES2402322T3 (es)	2013-04-30
IL205746A0 (en)	2010-11-30
JP2011503117A (ja)	2011-01-27
US7956068B2 (en)	2011-06-07
CA2705312A1 (en)	2009-05-22
CL2008003405A1 (es)	2010-02-12
CA2705312C (en)	2013-06-25
AU2008323561A1 (en)	2009-05-22
EP2220095B1 (en)	2013-01-02
RU2010123989A (ru)	2011-12-20
AU2008323561B2 (en)	2013-07-18
BRPI0819328A8 (pt)	2016-02-10
KR20100108337A (ko)	2010-10-06
US20100305115A1 (en)	2010-12-02
AR069334A1 (es)	2010-01-13
CN102124011A (zh)	2011-07-13
NZ585297A (en)	2012-06-29
EP2574610A1 (en)	2013-04-03

Publication	Publication Date	Title
BRPI0820307A2 (pt)	2019-09-24	inibidores de replicação do vírus da imunodeficiência humana
BRPI1010644A2 (pt)	2016-03-15	inibidores da replicação do vírus da imunodeficiência humana
ES2352576T8 (es)	2011-11-22	Inhibidores de la replicación del virus de la inmunodeficiencia humana.
DK2220076T3 (da)	2012-05-14	Inhibitorer af replikationen af humant immundefektvirus
LTC2140867I2 (lt)	2018-11-12	Farmacinė kompozicija
DK2346552T4 (da)	2020-03-23	Lægemiddelafgivelsesanordning og fremgangsmåde til fremstilling af en lægemiddelafgivelsesanordning
DE602008005653D1 (de)	2011-05-05	Femurtrochlea-Prothese
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
IL205746A0 (en)	2010-11-30	Inhibitors of human immunodeficiency virus replication
DK3348232T3 (da)	2020-05-18	Stentelement
BRPI0813707A2 (pt)	2014-12-30	Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
EP2131749A4 (en)	2014-04-02	Surgical stapling apparatus
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
BRPI0812518A2 (pt)	2015-03-31	Derivados de indazolamida
EP2206502A4 (en)	2014-01-15	POLYMER CONJUGATE OF A STEROIDS
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0814718A2 (pt)	2015-02-24	Derivados de isoxazol-imidazol
BRPI0811094A2 (pt)	2014-12-09	Derivados de heteroarilamida pirimidona

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2016-01-19	B25A	Requested transfer of rights approved	Owner name: GILEAD SCIENCES LIMITED (IE)
2016-02-10	B25A	Requested transfer of rights approved	Owner name: GILEAD SCIENCES, INC. (US)
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.